Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kingsbury

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|October 29, 1993
Trisubstituted pyridine leukotriene B4 receptor antagonists: synthesis and structure-activity relationshipsR A Daines, P A Chambers, I Pendrak, et al.
Journal of Medicinal Chemistry|October 29, 1993
Synthesis of structural analogs of leukotriene B4 and their receptor binding activityW D Kingsbury, I Pendrak, J D Leber, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1995
SB 209247, a high affinity LTB4 receptor antagonist demonstrating potent antiinflammatory activityH M Sarau, J J Foley, D B Schmidt, et al.
Cancer Chemotherapy and Pharmacology|June 8, 2001
Antagonism of oestrogen action in human breast and endometrial cells in vitro: potential novel antitumour agentsM E Nuttall, I Pendrak, J G Emery, et al.
Journal of Medicinal Chemistry|September 13, 1996
(E)-3-[6-[[(2,6-dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2- pyridinyl]-2-propenoic acid: a high-affinity leukotriene B4 receptor antagonist with oral antiinflammatory activityR A Daines, P A Chambers, J J Foley, et al.
Plos Pathogens|August 8, 2014
The Vi capsular polysaccharide enables Salmonella enterica serovar typhi to evade microbe-guided neutrophil chemotaxisTamding Wangdi, Cheng-Yuk Lee, Alanna M Spees, et al.
Journal of Medicinal Chemistry|September 30, 1994
(E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid and related compounds: high affinity leukotriene B4 receptor antagonistsR A Daines, P A Chambers, D S Eggleston, et al.
Journal of Medicinal Chemistry|January 1, 1991
Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activityW D Kingsbury, J C Boehm, D R Jakas, et al.
Journal of Medicinal Chemistry|March 1, 1989
Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activityR P Hertzberg, M J Caranfa, K G Holden, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47Joseph Weinstock, Jian Wu, Ping Cao, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|October 29, 1993
Trisubstituted pyridine leukotriene B4 receptor antagonists: synthesis and structure-activity relationshipsR A Daines, P A Chambers, I Pendrak, et al.
Journal of Medicinal Chemistry|October 29, 1993
Synthesis of structural analogs of leukotriene B4 and their receptor binding activityW D Kingsbury, I Pendrak, J D Leber, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1995
SB 209247, a high affinity LTB4 receptor antagonist demonstrating potent antiinflammatory activityH M Sarau, J J Foley, D B Schmidt, et al.
Cancer Chemotherapy and Pharmacology|June 8, 2001
Antagonism of oestrogen action in human breast and endometrial cells in vitro: potential novel antitumour agentsM E Nuttall, I Pendrak, J G Emery, et al.
Journal of Medicinal Chemistry|September 13, 1996
(E)-3-[6-[[(2,6-dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2- pyridinyl]-2-propenoic acid: a high-affinity leukotriene B4 receptor antagonist with oral antiinflammatory activityR A Daines, P A Chambers, J J Foley, et al.
Plos Pathogens|August 8, 2014
The Vi capsular polysaccharide enables Salmonella enterica serovar typhi to evade microbe-guided neutrophil chemotaxisTamding Wangdi, Cheng-Yuk Lee, Alanna M Spees, et al.
Journal of Medicinal Chemistry|September 30, 1994
(E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid and related compounds: high affinity leukotriene B4 receptor antagonistsR A Daines, P A Chambers, D S Eggleston, et al.
Journal of Medicinal Chemistry|January 1, 1991
Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activityW D Kingsbury, J C Boehm, D R Jakas, et al.
Journal of Medicinal Chemistry|March 1, 1989
Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activityR P Hertzberg, M J Caranfa, K G Holden, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47Joseph Weinstock, Jian Wu, Ping Cao, et al.
Pageof 6